Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Castration-resistant”

1,087 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,087 results

Not applicableStudy completedNCT04425200
What this trial is testing

Prevalence of HRR-related Genes Mutations and Prognosis in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients in Real World Setting

Who this might be right for
Prostatic Neoplasms
AstraZeneca 205
Testing effectiveness (Phase 2)Ended earlyNCT02146833
What this trial is testing

SHIP (Selinexor in Hormone Insensitive Prostate Cancer)

Who this might be right for
Prostate Cancer
Karyopharm Therapeutics Inc 20
Very early researchNot Yet RecruitingNCT07389187
What this trial is testing

Safety and Preliminary Efficacy Evaluation of LC-K76 Plus Anti-PD-1 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Who this might be right for
mCRPC
Shanghai Changzheng Hospital 10
Early research (Phase 1)Active Not RecruitingNCT04898634
What this trial is testing

JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 216
Large-scale testing (Phase 3)Not Yet RecruitingNCT06768255
What this trial is testing

Phase III Study of Abiraterone Acetate (II) Versus Abiraterone Acetate in Patients with MCRPC

Who this might be right for
Abiraterone AcetateMCRPC (metastatic Castration-resistant Prostate Cancer)
Ding-Wei Ye 400
Testing effectiveness (Phase 2)WithdrawnNCT01478308
What this trial is testing

Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
New Mexico Cancer Research Alliance
Testing effectiveness (Phase 2)Study completedNCT02952534
What this trial is testing

Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
pharmaand GmbH 277
Early research (Phase 1)Ended earlyNCT04740034
What this trial is testing

AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate Carcinoma

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Amgen 42
Early research (Phase 1)Ended earlyNCT03137758
What this trial is testing

A Phase I Study of PCUR-101 in Combination With Androgen Suppression Therapy in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Pellficure Pharmaceuticals, Inc 12
Early research (Phase 1)Study completedNCT04087174
What this trial is testing

A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
AstraZeneca 27
Testing effectiveness (Phase 2)Ended earlyNCT02656615
What this trial is testing

Abiraterone-Rechallenge Study for CRPC Patients

Who this might be right for
Prostate Cancer
Aurelius Omlin 4
Testing effectiveness (Phase 2)Ended earlyNCT05501548
What this trial is testing

Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer

Who this might be right for
Prostate CancerCastration-resistant Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 4
Large-scale testing (Phase 3)Looking for participantsNCT06629779
What this trial is testing

Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Pfizer 900
Testing effectiveness (Phase 2)Active Not RecruitingNCT06056791
What this trial is testing

Study of INKmune in Patients With mCRPC (CaRe Prostate)

Who this might be right for
CancerMetastatic Castration-resistant Prostate CancermCRPC
Inmune Bio, Inc. 30
Testing effectiveness (Phase 2)Looking for participantsNCT07117760
What this trial is testing

Prospective Clinical Trial of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
First Affiliated Hospital of Fujian Medical University 20
Not applicableStudy completedNCT04662996
What this trial is testing

Search for Predictive Factors of Resistance to Treatment for Metastatic Castration-resistant Prostate Cancer by Studying the Expression of microRNAs

Who this might be right for
Prostate CancerResistance, DiseaseMicroRNAs
University Hospital, Tours 33
Testing effectiveness (Phase 2)Study completedNCT03365791
What this trial is testing

PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies

Who this might be right for
Small Cell Lung CancerGastric AdenocarcinomaEsophageal Adenocarcinoma+5 more
Novartis Pharmaceuticals 76
Testing effectiveness (Phase 2)Study completedNCT01560923
What this trial is testing

Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Masonic Cancer Center, University of Minnesota 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT04946370
What this trial is testing

Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 37
Large-scale testing (Phase 3)Active Not RecruitingNCT02194842
What this trial is testing

Phase III Radium 223 mCRPC-PEACE III

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 446
Load More Results